ARGEN by Yokogawa Fluence Analytics is a real-time analytics platform that accelerates the discovery, formulation, and optimization of stable biotherapeutics. Instead of relying on delayed, periodic snapshots, ARGEN continuously monitors molecular stability and aggregation for up to eight independent experiments simultaneously. Watch this short overview video to see how ARGEN seamlessly integrates into existing workflows and delivers immediate insight.
Biotherapeutics must remain stable under thermal, mechanical, and chemical stress throughout development and manufacturing. ARGEN helps teams build a complete stability profile early—reducing downstream risk.
• Identify the onset of aggregation and instability
• More efficient formulation development
• Improved downstream performance
ARGEN uses patented static light scattering technology to detect subtle changes in molecular weight as experiments progress. This approach allows teams to:
• Observe aggregation and degradation in situ
• Shorten development cycles
• Make faster, data-driven decisions
ARGEN evaluates stability across multiple stress conditions simultaneously. Capabilities include:
• Thermal, chemical, and mechanical stress testing
• Eight parallel, independent experiments
• Clear visualization of stability landscapes
Whether advancing monoclonal antibodies, nucleic acid therapeutics, or complex biologic formulations, ARGEN supports critical stages of biologics development. By combining real-time understanding with predictive analytics, teams can rapidly iterate formulations and confidently advance promising candidates into manufacturing. Reach out today to learn how ARGEN helps teams bring safer, more effective therapies to market faster.